<p>，/PRNewswire/ -- Genesis Innovation Group (GIG) 是一家总部位于美国的医疗设备开发公司，负责将概念从构思转化为商业化，宣布成立其最新子公司 Capitan Orthopedics, Inc.</p>
<p>Capitan Orthopedics 的 SupraSpacerTM 微创植入物提供了一种长期的生物力学解决方案，解决不可修复的肩袖撕裂问题。SupraSpacerTM 植入物恢复关节对齐，并允许无痛的活动范围，同时保留未来的手术选择。</p>
<p>“如今，每年有超过 200 万人被诊断为肩袖损伤，超过 700,000 人接受手术修复主要的肩袖撕裂。但是，目前护理连续体中存在巨大的空白，长期以来，患有不可修复肩袖撕裂的患者面临有限的手术选择和没有长期解决方案的困境。我们的专家设计外科医生和工程师团队创造了一种新型植入物和简单、可重复的手术程序，为外科医生提供了一种急需的手术选择，积极影响患者护理，” Genesis Innovation Group 和 Capitan Orthopedics, Inc. 的首席执行官 Chance Leonard 说道。</p>
<p>首席外科设计师 R. Sean Churchill 医生表示：“与 Capitan Orthopedics 合作令人兴奋，因为该公司承担了应对当今骨科外科医生面临的最常见和最令人沮丧的肩部疾病之一的挑战——在 25 至 60 岁患者中出现的疼痛性不可修复肩袖撕裂。几代人以来，外科医生尝试了从物理治疗、注射、肌腱转移到关节囊重建的各种方法。不幸的是，这些治疗往往失败，使患者感到沮丧，肩部疼痛、虚弱且功能不良。SupraSpacerTM 专为这些患者设计。通过帮助保持肱骨头在关节中的中心，植入物不仅降低了肩关节炎的风险和进展，还消除了肱骨头在肩峰下表面的疼痛接触，从而允许完全无夹击的活动范围。”</p>
<p>Leonard 先生补充道：“不可修复的肩袖撕裂影响着相当数量的患者群体，我们相信一种简单但持久、可重复的微创、节省骨骼的手术程序既是外科医生会接受的解决方案，也是患者会感激的解决方案。我们迫切希望尽快将 SupraSpacerTM 推向市场。”</p>
<p><strong>关于 Genesis Innovation Group</strong></p>
<p>Genesis Innovation Group 是医疗设备开发和商业化的领导者。该公司与发明家、企业家和早期阶段的医疗设备公司合作，开发创新技术，积极影响患者护理并提供更好的患者结果。Genesis 团队拥有 377 年的工程经验，获得了 227 项专利，生成了 154 项 510k 清关，并帮助实现了 13 次成功退出。</p>
<p>了解更多关于 Genesis Innovation Group 和 Capitan Orthopedics, Inc. 的信息，请访问： https://genesisinnovationgroup.com 和 capitanortho.com。</p>
<p>Jill Wachter</p>
<p>https://genesisinnovationgroup.com</p>
<p>来源：Genesis Innovation Group</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIwJk5ld3NJdGVtSWQ9Rkw2NTQ2NSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjAwNTI1UFJfTkVXU19VU1BSX19fX19GTDY1NDY1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIwJk5ld3NJdGVtSWQ9Rkw2NTQ2NSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjAwNTI1UFJfTkVXU19VU1BSX19fX19GTDY1NDY1"/></p>

<p>Genesis Innovation Group (GIG) 宣布成立其新子公司 Capitan Orthopedics, Inc.，该公司将专注于为患有不可修复的肩袖撕裂的患者设计 SupraSpacerTM 植入物。这种微创植入物旨在恢复关节对齐，并为每年超过 200 万例肩袖损伤诊断提供长期解决方案。首席执行官 Chance Leonard 强调了为遭受这种病症的患者提供更好外科选择的必要性，而首席外科设计师 R. Sean Churchill 则强调了该植入物改善患者结果和降低肩关节炎风险的潜力</p>

<p>, /PRNewswire/ -- Genesis Innovation Group (GIG), a U.S.-based medical device development firm that takes concepts from ideation to commercialization, announces the formation of its newest subsidiary, Capitan Orthopedics, Inc.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Genesis Innovation Group (GIG) 是一家总部位于美国的医疗设备开发公司，负责将概念从构思转化为商业化，宣布成立其最新子公司 Capitan Orthopedics, Inc.</p>
</div><p>Capitan Orthopedics' SupraSpacerTM minimally invasive implant provides a long-term, biomechanical solution that addresses irreparable rotator cuff tears. The SupraSpacerTM implant restores joint alignment and allows for pain free range of motion, while also preserving future surgical options.</p>
<div class="lb-trans"><p>Capitan Orthopedics 的 SupraSpacerTM 微创植入物提供了一种长期的生物力学解决方案，解决不可修复的肩袖撕裂问题。SupraSpacerTM 植入物恢复关节对齐，并允许无痛的活动范围，同时保留未来的手术选择。</p>
</div><p>&#34;Today, over 2 million people a year are diagnosed with a rotator cuff injury and over 700,000+ undergo surgery to repair a primary rotator cuff tear. But, there is a massive gap in the current care continuum and for far too long patients with irreparable cuff tears have suffered with limited surgical options and no long-term solution. Our team of expert design surgeons and engineers have created a novel implant and a simple, reproducible procedure that provides surgeons with a desperately needed surgical option that positively impacts patient care,&#34; said Chance Leonard, CEO of Genesis Innovation Group and Capitan Orthopedics, Inc.</p>
<div class="lb-trans"><p>“如今，每年有超过 200 万人被诊断为肩袖损伤，超过 700,000 人接受手术修复主要的肩袖撕裂。但是，目前护理连续体中存在巨大的空白，长期以来，患有不可修复肩袖撕裂的患者面临有限的手术选择和没有长期解决方案的困境。我们的专家设计外科医生和工程师团队创造了一种新型植入物和简单、可重复的手术程序，为外科医生提供了一种急需的手术选择，积极影响患者护理，” Genesis Innovation Group 和 Capitan Orthopedics, Inc. 的首席执行官 Chance Leonard 说道。</p>
</div><p>R. Sean Churchill, MD, MBA, lead surgeon designer said, &#34;It's exciting to work with Capitan Orthopedics as the company has taken on the challenge of addressing one of the most common and frustrating shoulder conditions facing orthopedic surgeons today - the painful, irreparable, rotator cuff tear in patients aged 25-60. For generations, surgeons have tried everything from physical therapy, injections, tendon transfers and capsular reconstructions. Unfortunately, and all too often, these treatments fail and leave the patients frustrated with painful, weak, and poorly functioning shoulders. The SupraSpacerTM is specifically designed for these patients. By helping maintain the humeral head centered in the joint, the implant not only reduces the risk and advancement of shoulder arthritis, but removes the painful abutment of the humeral head on the undersurface of the acromion, allowing for full impingement free range of motion.&#34;</p>
<div class="lb-trans"><p>首席外科设计师 R. Sean Churchill 医生表示：“与 Capitan Orthopedics 合作令人兴奋，因为该公司承担了应对当今骨科外科医生面临的最常见和最令人沮丧的肩部疾病之一的挑战——在 25 至 60 岁患者中出现的疼痛性不可修复肩袖撕裂。几代人以来，外科医生尝试了从物理治疗、注射、肌腱转移到关节囊重建的各种方法。不幸的是，这些治疗往往失败，使患者感到沮丧，肩部疼痛、虚弱且功能不良。SupraSpacerTM 专为这些患者设计。通过帮助保持肱骨头在关节中的中心，植入物不仅降低了肩关节炎的风险和进展，还消除了肱骨头在肩峰下表面的疼痛接触，从而允许完全无夹击的活动范围。”</p>
</div><p>Mr. Leonard added, &#34;Irreparable rotator cuff tears affect a sizable patient population and we believe that a simple, but lasting, repeatable, minimally-invasive, bone-sparing procedure is both a solution surgeons will embrace, and one that patients will appreciate. We are eager to bring SupraSpacerTM to the market as soon as possible.&#34;</p>
<div class="lb-trans"><p>Leonard 先生补充道：“不可修复的肩袖撕裂影响着相当数量的患者群体，我们相信一种简单但持久、可重复的微创、节省骨骼的手术程序既是外科医生会接受的解决方案，也是患者会感激的解决方案。我们迫切希望尽快将 SupraSpacerTM 推向市场。”</p>
</div><p><strong>About Genesis Innovation Group</strong></p>
<div class="lb-trans"><p><strong>关于 Genesis Innovation Group</strong></p>
</div><p>Genesis Innovation Group is the leader in medical device development and commercialization. The company partners with inventors, entrepreneurs, and early stage medical device companies to develop innovative technologies that positively impact patient care and deliver better patient outcomes. The Genesis team has a combined 377 years of engineering experience, has amassed 227 patents, has generated 154 510k clearances and has helped deliver 13 successful exits.</p>
<div class="lb-trans"><p>Genesis Innovation Group 是医疗设备开发和商业化的领导者。该公司与发明家、企业家和早期阶段的医疗设备公司合作，开发创新技术，积极影响患者护理并提供更好的患者结果。Genesis 团队拥有 377 年的工程经验，获得了 227 项专利，生成了 154 项 510k 清关，并帮助实现了 13 次成功退出。</p>
</div><p>Learn more about Genesis Innovation Group and Capitan Orthopedics, Inc. at: https://genesisinnovationgroup.com and capitanortho.com.</p>
<div class="lb-trans"><p>了解更多关于 Genesis Innovation Group 和 Capitan Orthopedics, Inc. 的信息，请访问： https://genesisinnovationgroup.com 和 capitanortho.com。</p>
</div><p>Jill Wachter</p>
<div class="lb-trans"><p>Jill Wachter</p>
</div><p>https://genesisinnovationgroup.com</p>
<div class="lb-trans"><p>https://genesisinnovationgroup.com</p>
</div><p>SOURCE Genesis Innovation Group</p>
<div class="lb-trans"><p>来源：Genesis Innovation Group</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIwJk5ld3NJdGVtSWQ9Rkw2NTQ2NSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjAwNTI1UFJfTkVXU19VU1BSX19fX19GTDY1NDY1" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=FL65465&amp;Transmission_Id=202601200525PR_NEWS_USPR_____FL65465&amp;DateId=20260120"/></p>

创世纪创新集团宣布成立新子公司 Capitan Orthopedics, Inc